Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-20

Clinical Trial Update: Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP)) [NA]

View source ↗

Summary

A completed clinical trial comparing mifepristone plus misoprostol versus misoprostol alone for second-trimester induced abortion (14-21 weeks LMP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MISOPROSTOL (Misoprostol)
  • Mifepristone (mifepristone)

Snippet

Sponsor: Gynuity Health Projects | Conditions: Abortion, Induced | NA | Status: COMPLETED